Daniel J Renouf

12PUBLICATIONS
94CO-AUTHORS
AutoimmunityPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Sep 18, 2026
Compartment-specific CD8 infiltration and disease-specific survival in resected ampullary adenocarcinoma.

|May 26, 2026
Clinical and Molecular Correlates of Circulating Tumor Fraction in Patients with Metastatic Pancreatic Ductal Adenocarcinoma.

|Mar 07, 2026
DNA Repair gene alterations and efficacy from gemcitabine and nab-paclitaxel with/without durvalumab and tremelimumab in metastatic pancreatic ductal adenocarcinoma.

Daniel J Renouf, James T Topham, Jonathan M Loree

|Jul 04, 2025
Neutrophil extracellular trap gene expression signatures identify prognostic and targetable signaling axes for inhibiting pancreatic tumour metastasis.

Paul C McDonald, James T Topham, Shannon Awrey

|Apr 04, 2025
The tandem duplicator phenotype may be a novel targetable subgroup in pancreatic cancer.

Abdul R Farooq, Amy X Zhang, Michelle Chan-Seng-Yue

|Feb 21, 2025
Safety and Antitumor Activity of a Novel aCD25 Treg Depleter RG6292 as a Single Agent and in Combination with Atezolizumab in Patients with Solid Tumors.

Valentina Gambardella, Michael Ong, Maria E Rodriguez-Ruiz

Pageof 2

Frequent Collaborators

8 joint publications

Jonathan M Loree

5 joint publications

Sharlene Gill

4 joint publications

Emma Titmuss

3 joint publications

Marco Marra